Science & Technology in Action


The Genzyme Ireland plant is in Waterford City in the South East of Ireland. Established in 2001, it is located on a 37 acre site. Tablet and sachet products are manufactured in the oral dose manufacturing facility.

The fill finish facility is used for the aseptic filling of biologics including enzyme replacement therapies in the Genzyme rare disease portfolio. The filling and lyophilisation capacity at the site places the Waterford plant at the heart of the Genzyme supply chain. The packaging facility has sachet, vial and bottle packaging lines. An extensive range of product testing and release to market is performed with distribution to over 70 countries worldwide.

The site has invested in state of the art infrastructure and technology, reflecting the niche nature and high value of the products produced there. It also has clinical trial manufacturing capability. The pilot scale facility provides product development, technical transfer and process trouble shooting capability. The Quality Systems have been audited by leading regulatory bodies from around the world and Genzyme Ireland has an excellent quality and compliance track record. Operational excellence is a key site enabler and continuous improvement processes are grounded in best practice and involve those closest to the operations.

Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over thirty years. It accomplishes its goals through world-class research and with the compassion and commitment of its employees. With a focus on rare diseases, the company is dedicated to making a positive impact on the lives of the patients and families it serves. Genzyme’s portfolio of transformative therapies, which are marketed around the world, represents groundbreaking and life-saving advances in medicine.

As a Sanofi company, Genzyme benefits from the research and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients.

Find out more about the work of Genzyme at